Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.
about
Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejectionTherapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.In vivo T cell tumor therapy with monoclonal antibody directed to the V beta chain of T cell antigen receptor.
P2860
Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Therapy of murine leukemia wit ...... ormal differentiation antigen.
@ast
Therapy of murine leukemia wit ...... ormal differentiation antigen.
@en
type
label
Therapy of murine leukemia wit ...... ormal differentiation antigen.
@ast
Therapy of murine leukemia wit ...... ormal differentiation antigen.
@en
prefLabel
Therapy of murine leukemia wit ...... ormal differentiation antigen.
@ast
Therapy of murine leukemia wit ...... ormal differentiation antigen.
@en
P2860
P356
P1476
Therapy of murine leukemia wit ...... ormal differentiation antigen.
@en
P2093
C C Badger
I D Bernstein
P2860
P304
P356
10.1084/JEM.157.3.828
P407
P577
1983-03-01T00:00:00Z